Trial: 201510064

ADVL1414 – A Phase I Study of Selinexor (KPT-330, IND #125052), A Selective XPO1 Inhibitor, in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors

Phase

I

Principal Investigator

Hayashi, Robert

Disease Site

Bones and Joints; Brain and Nervous System; Esophagus; Liver; Other Digestive Organ; Other Endocrine System; Pancreas; Pediatric Cancers; Sarcoma; Small Intestine; Soft Tissue; Stomach

Learn more about this study at: clinicaltrials.gov